JPM Research Update — June 20, 2026
Updated Thesis
JPMorgan Chase & Co. is a leading global financial services firm with a diversified banking franchise spanning consumer, corporate, commercial, and asset management segments. The company benefits from a durable competitive moat supported by a long-tenured CEO, strong management continuity, and leading market shares in key banking sectors.
The investment grade as of this refresh is A — high business quality. High-tier business, fair-tier valuation
Key Metrics at a Glance
- Revenue growth: +6.9% year over year
- Net margin: 20.7%
- Forward P/E: 15.6x
- Fair value upside: +45.0% to our estimate of $472
Current price: $325.22
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. JPMorgan Chase & Co. remains in our covered universe with a high-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full JPM research →](/stocks/JPM)